advertisement
Abstract #16821 Published in IGR 9-1
Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma
Roedl JB; Bleich S; Reulbach U; Rejdak R; Kornhuber J; Kruse FE; Schlötzer-Schrehardt U; Jünemann AGJournal of Glaucoma 2007; 16: 234-239
PURPOSE: To evaluate homocysteine (Hcy) concentrations in tear fluid and plasma and their association with B-vitamin levels in patients with pseudoexfoliation glaucoma (PEXG). PATIENTS AND METHODS: Reflex tear and blood samples were obtained in 30 patients with PEXG and 30 controls. Hcy levels were determined by high-performance liquid chromatography. RESULTS: Hcy was detected in all tear fluid samples of patients with PEXG and controls. Statistical analysis with t tests showed that patients with PEXG had significantly higher Hcy levels both in tear fluid (237 ± 133 nmol/L vs. 128 ± 54 nmol/L; P < 0.001) and in plasma (14.51 ± 4.43 [mu]mol/L vs. 10.22 ± 2.77 [mu]mol/L; P < 0.001) than control subjects. Hcy in tear fluid correlated significantly with Hcy in plasma (r = 0.438, P = 0.015) and with serum B12 levels (r = -0.424, P = 0.019) in patients with PEXG, but not in controls. CONCLUSIONS: The study suggests increased Hcy levels in tear fluid and plasma of patients with PEXG. Further investigations are needed to evaluate the possible clinical role of Hcy in ocular surface and systemic disorders associated with PEXG.
Dr. J.B. Roedl, Department of Ophthalmology and University Eye Hospital, Germany. Johannes.Roedl@augen.imed.uni-erlangen.de
Classification:
9.4.4.1 Exfoliation syndrome (Part of: 9 Clinical forms of glaucomas > 9.4 Glaucomas associated with other ocular and systemic disorders > 9.4.4 Glaucomas associated with disorders of the lens)
3.7 Biochemistry (Part of: 3 Laboratory methods)
